The Valley Desk

NCT07007312 · Interventional trial

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Overall registry status Recruiting

Phase 3

Conditions Acute Myeloid Leukemia (AML)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov